tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Passage Bio Reports Promising Q2 2025 Financial Results
PremiumCompany AnnouncementsPassage Bio Reports Promising Q2 2025 Financial Results
3M ago
Passage Bio reports Q2 EPS ($2.96) vs ($5.09) last year
Premium
The Fly
Passage Bio reports Q2 EPS ($2.96) vs ($5.09) last year
3M ago
Passage Bio expects cash to fund operations into Q1 of 2027
Premium
The Fly
Passage Bio expects cash to fund operations into Q1 of 2027
3M ago
Passage Bio announces 1-for-20 reverse stock split
PremiumThe FlyPassage Bio announces 1-for-20 reverse stock split
4M ago
Optimistic Buy Rating for Passage Bio’s PBFT02: Promising Efficacy and Managed Safety Concerns
Premium
Ratings
Optimistic Buy Rating for Passage Bio’s PBFT02: Promising Efficacy and Managed Safety Concerns
4M ago
Passage Bio’s Promising Clinical Trial Results and Strategic Adjustments Justify Buy Rating
Premium
Ratings
Passage Bio’s Promising Clinical Trial Results and Strategic Adjustments Justify Buy Rating
4M ago
Passage Bio price target lowered to $2 from $4 at Guggenheim
PremiumThe FlyPassage Bio price target lowered to $2 from $4 at Guggenheim
6M ago
Passage Bio’s Strategic Positioning and Growth Potential: A Buy Rating Analysis
Premium
Ratings
Passage Bio’s Strategic Positioning and Growth Potential: A Buy Rating Analysis
6M ago
Passage Bio: Steady Progress and Financial Stability Reinforce Buy Rating with $13 Target
Premium
Ratings
Passage Bio: Steady Progress and Financial Stability Reinforce Buy Rating with $13 Target
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100